VanDevanter, D., Yegin, A., Morgan, W., Millar, S., Pasta, D., & Konstan, M. (2011). DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING PULMONARY EXACERBATION AS AN EFFICACY ENDPOINT.
Chicago Style CitationVanDevanter, DR, A. Yegin, WJ Morgan, SJ Millar, DJ Pasta, i MW Konstan. DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING PULMONARY EXACERBATION AS AN EFFICACY ENDPOINT. 2011.
Cita MLAVanDevanter, DR, et al. DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING PULMONARY EXACERBATION AS AN EFFICACY ENDPOINT. 2011.
Atenció: Aquestes cites poden no estar 100% correctes.